Results 271 to 280 of about 87,437 (368)

Nanoscale chemical imaging of individual chemotherapeutic cytarabine-loaded liposomal nanocarriers

Nano Reseach, 2018
K. Wieland, G. Ramer, V. Weiss, G. Allmaier, B. Lendl, A. Centrone   +5 more
semanticscholar   +1 more source

Precision oncology to overcome resistance in R/R AML in children and adults requires combinations of cytotoxic, targeted, and immunological treatments

Journal of Internal Medicine, Volume 298, Issue 4, Page 297-318, October 2025.
Abstract Although outcomes for newly diagnosed acute myeloid leukaemia (AML) have been incrementally improved over the last decades, management of relapsed and refractory (R/R) AML remains a medical challenge. A curative intent for R/R AML usually involves chemotherapy (with or without targeted therapy) with subsequent consolidation, including ...
Martin Jädersten, Ingrid Lilienthal, Christer Nilsson, Louisa Fredrikson, Cornelis Jan Pronk, Kristian Løvvik Juul‐Dam, Mika Kontro, Nikolas Herold   +7 more
wiley   +1 more source

Bing-Neel syndrome: a case series of 46 patients from the United Kingdom. [PDF]

Blood Adv
Tomkins O, Khwaja J, Koay S, Japzon N, Hoskote C, Gupta R, Baker R, Lindsay J, Kyriakou C, Lunn MP, D'Sa S.   +10 more
europepmc   +1 more source

56 Allogeneic stem cell transplantation using high-dose cytarabine combined with G-SCF and TBI as conditioning for chronic myelogenours leukemia (CML) in advanced stage

, 2003
Risa Yamazaki, Takeshi Mori, Takashi Shimizu, Yoshinobu Aisa, Yasushi Ikeda, Soichiro Okamoto   +5 more
openalex   +1 more source

t(8;21)AML patients with RUNX1e6::RUNX1T19a splice variant have poor prognosis. [PDF]

Ann Hematol
Fan Y, Chen L, Liu S, Dang J, Chang J, Guo C, Xu Y, Guo W, Wang H, Tan Y.   +9 more
europepmc   +1 more source

The possibility of aphidicolin as a drug for circumventing cytarabine-resistance in human leukemic cells.

, 2003
Yasukazu Kawai, Haruyuki Takemura, Takanori Ueda   +2 more
openalex   +2 more sources

Quadriparesis after CD19 × CD22 bicistronic chimeric antigen receptor T cells for B‐cell acute lymphoblastic leukaemia

British Journal of Haematology, Volume 207, Issue 4, Page 1673-1678, October 2025.
Alexander W. Rankin, Sara K. Silbert, Brynn B. Duncan, Bonnie Yates, Avindra Nath, Nadia Biassou, Anthony F. Suffredini, Robert L. Danner, Charles Natanson, Amarpreet K. Ahluwalia, Lauren Little, Toni Foley, Hemant S. Murthy, Haneen Shalabi, Paul Nyquist, Nirali N. Shah   +15 more
wiley   +1 more source

Bone marrow lymphocyte dynamics during chemotherapy in pediatric acute myeloid leukemia. [PDF]

Hemasphere
Koedijk JB, Barneh F, Meesters-Ensing JE, van Tuil M, Sonneveld E, Lambo S, Perzolli A, Schweighart EK, Ferrao Blanco MN, van der Meulen M, Deli A, Haasjes E, Bang Christensen K, de Groot-Kruseman HA, Meshinchi S, Hasle H, Belderbos ME, Luesink M, Goemans BF, Nierkens S, Hehir-Kwa J, Zwaan CM, Heidenreich O.   +22 more
europepmc   +1 more source

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.

New England Journal of Medicine, 2003
T. Hughes, J. Kaeda, S. Branford, Z. Rudzki, A. Hochhaus, M. Hensley, I. Gathmann, A. Bolton, Iris van Hoomissen, J. Goldman, J. Radich   +10 more
semanticscholar   +1 more source

Treatment-related Changes in Cerebrospinal Fluid Markers of Oxidative Stress and Neurodegeneration During Therapy for Childhood Acute Lymphoblastic Leukemia. [PDF]

Cancer Epidemiol Biomarkers Prev
Park Y, K C N, Willekens J, Patel C, Savage BA, Lin H, Paneque A, Daly R, Thrope A, Burns MA, Welch JJ, Kahn JM, Kelly KM, Tran TH, Michon B, Gennarini L, Silverman LB, Sands SA, Cole PD.   +18 more
europepmc   +1 more source